New Approach for Ovarian PRP Injection for Poor Responders
NCT ID: NCT06663930
Last Updated: 2024-10-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
21 participants
OBSERVATIONAL
2024-03-01
2025-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Platelet Rich Plasma on Ovarian Reserve Parameters and Intra Cytoplasmic Sperm Injection Outcomes in Patients With Diminished Ovarian Reserve
NCT06048666
Autologous Platelet-Rich Plasma Intra-ovarian Infusion in Poor Responders
NCT03937661
Autologous PRP Intra Ovarian Infusion to Restore Ovarian Function in Menopausal Women
NCT03916978
Ovarian Injection of PRP (Platelet -Rich Plasma) Vs Normal Saline in Premature Ovarian Insufficiency
NCT04922398
Platelet Rich Plasma Injection Into Ovary of Patients With Premature Ovarian Insufficiency
NCT04149028
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* FSH: \> 10 miu but \< 25 miu.
* AFC : \< 5 in both ovaries
* Poor ovarian response, in a previous IVF/ICSI trial , resulting in 3 or fewer oocytes.
* Normal uterine cavity , demonstrated by a recent hysteroscopy
Exclusion Criteria
* Previous ovarian surgery or Chemotherapy.
* On going Anticoagulant use.
* Carcinomas or a history of chronic pelvic pain.
* Present infection.
* Hemoglobin level lower than 11 g/L
* platelet count lower than 150 x 10³/μL.
30 Years
40 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bassem Ayman Mahmoud Assaf
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bassem Ayman Mahmoud Assaf
Medical Doctor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Benha University
Banhā, benha, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
New Approach For Ovarian PRP
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.